Results 1 - 8 from 8 for "bioeel"
-
Bioeel’s Pharmaceutical Distribution Business Overshoots RON1B Revenue Mark In 2024
05.23.2025
Pharmaceutical company Bioeel posted RON1.2 billion revenue from its pharmaceutical distribution business in Romania in 2024, an increase of about 37% year-on-year, Finance Ministry data show. This is more
-
Pharma Group Bioeel 1Q/2023 Turnover Rises 40% To over RON215M
05.31.2023
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first quarter of this year raked in turnover of above RON215 million (around more
-
Pharma Group Bioeel Expects RON710M Turnover in 2023, Up 3.5% YOY
03.06.2023
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, projects total turnover worth around RON710.6 million in 2023 (around EUR144 million) at more
-
Pharma Group Bioeel Ends 2022 with RON686M Turnover, Up 22% YOY
01.26.2023
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2022 generated turnover worth around RON686.4 million (EUR139.5 million) at group more
-
Pharma Group Bioeel Expects RON630M Turnover in 2022
12.23.2022
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, estimates it will generate turnover of around RON630 million (EUR127.5 million) by more
-
Pharma Group Bioeel Sees 1H/2022 Turnover Rise by 21% To over RON312M
10.11.2022
Pharma group Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first half of this year generated turnover worth RON312 million more
-
Pharma Group Bioeel Bets on 7-8% Turnover Growth in 2022
03.22.2022
Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, expects 7-8% turnover growth at group level for 2022 on the year. more
-
Pharma Group Bioeel Hits RON562M Turnover in 2021, Up 18% YOY
02.22.2022
Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2021 generated turnover worth RON562 million (EUR114.2 million), 18% more